PITCAIRN CO - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
PITCAIRN CO ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$342,083
+6.6%
2,822
+0.7%
0.03%
+3.6%
Q2 2023$320,771
-57.7%
2,801
-49.1%
0.03%
-60.0%
Q1 2023$757,789
-5.9%
5,498
-11.6%
0.07%
-12.5%
Q4 2022$805,599
+12.2%
6,217
-4.3%
0.08%
+2.6%
Q3 2022$718,000
+30.5%
6,493
-11.5%
0.08%
+34.5%
Q2 2022$550,000
-3.2%
7,340
+0.9%
0.06%
+18.4%
Q1 2022$568,000
+1.2%
7,272
+16.8%
0.05%
+36.1%
Q4 2021$561,000
-11.1%
6,225
-8.8%
0.04%
-18.2%
Q3 2021$631,000
+4.5%
6,828
-12.2%
0.04%
+7.3%
Q2 2021$604,000
+158.1%
7,775
+147.8%
0.04%
+141.2%
Q1 2021$234,000
-31.0%
3,138
+57.9%
0.02%
-34.6%
Q4 2020$339,000
+11.1%
1,987
-8.3%
0.03%0.0%
Q3 2020$305,000
-22.6%
2,168
-11.8%
0.03%
-31.6%
Q2 2020$394,000
+85.0%
2,459
+13.1%
0.04%
+52.0%
Q1 2020$213,000
-41.3%
2,174
-22.8%
0.02%
-26.5%
Q4 2019$363,000
+26.9%
2,816
+49.4%
0.03%
+17.2%
Q2 2019$286,000
+19.2%
1,885
-6.6%
0.03%
+11.5%
Q1 2019$240,0002,0190.03%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders